A disproportionality analysis of low molecular weight heparin in the overall population and in pregnancy women using the FDA adverse event reporting system (FAERS) database
This study identified unexpected AE signals of LMWH-relate in pregnancy women. Our study could provide valuable evidence for the clinical practice of LMWH, especially for identifying AEs and ensuring safe usage in pregnancy women.
Authors
- Huan Xu (ORCID: https://orcid.org/0000-0002-2815-4322)
- Ying-Ju Wang
- Ningning Xu (ORCID: https://orcid.org/0000-0002-6053-6742)
- Su Zhen Wu (ORCID: https://orcid.org/0000-0001-7672-0731)
- Haoxi Zou
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Foshan Hospital of TCM (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-08-12
- DOI
- https://doi.org/10.3389/fphar.2024.1442002
- Citations
- 7
- Primary Topic
- Heparin-Induced Thrombocytopenia and Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 4.01